Support for fast-tracking new drugs into clinical trials for childhood acute leukemia
Children's Cancer Institute welcomes its inclusion, by the US National Cancer Institute (NCI), in a systematic program of drug evaluation in childhood cancer.
Sep 8, 2015
0
14